The genomic and transcriptomic platforms provided by the Cancer Genomics Facility (CGF) enable a large number of diverse basic, translational, and clinical projects that fall predominantly into three research categories:
- Cancer center projects seeking to identify diagnostic biomarkers for cancer risk prediction, early detection, prognosis, and prediction of disease progression.
- Projects attempting to elaborate the underlying mechanisms of tumorigenesis in order to improve molecular classification, categorize risk of metastasis and recurrence, and optimize therapeutic approaches.
- Studies to delineate previously unknown targets for prospective pharmacological reagents that may lead to novel therapeutic targeting strategies.
The capabilities of the CGF have been tailored to meet the needs of these studies. Learn more about our services and equipment.